Tech Company Financing Transactions
Diakonos Oncology Funding Round
Diakonos Oncology closed a $11.4 million Seed financing round on 8/27/2024. Investors included RESTEM and private investors.
Transaction Overview
Company Name
Announced On
8/27/2024
Transaction Type
Venture Equity
Amount
$11,400,000
Round
Seed
Investors
RESTEM (Lead Investor)
Proceeds Purpose
To date, funds have enabled the company to establish manufacturing operations, add key leadership positions, and complete enrollment for the Phase 1 study of DOC1021 in the treatment of glioblastoma (GBM). The additional capital will fund operations into late 2025 and allow Diakonos to initiate the Phase 2 trial in GBM prior to closing a Series A round.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Shields Court
Trophy Club, TX 76262
USA
Trophy Club, TX 76262
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Diakonos Oncology, a clinical-stage biotechnology entity, was founded to address the critical and unmet medical need of late-stage and aggressive cancers . With a FDA Fast Track designation and unprecedented results in cancers such as Glioblastoma Multiforme (GBM), Diakonos moves closer each day to changing patient outcomes for these difficult indications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Dan Faust
Chief Executive Officer
Mike Wicks
Chief Operating Officer
Jay Hartenbach
Chief Scientific Officer
Will Decker
Chief Technical Officer
Matt Halpert
VP - Finance
Marcus Gohlke
VP - R & D
Vanaja Konduri
VP - Regulatory Affairs
Ian Bellayr
VP - Regulatory Affairs
Moya Daniels
Browse more venture capital transactions:
Prev: 8/27/2024: eXeX venture capital transaction
Next: 8/27/2024: Katara venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs